Ali Alhadab
Impact in
-
- Antifungal resistance and susceptibility
-
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Cytomegalovirus and herpesvirus research
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
- Oncology 5
- Lung Cancer Research Studies 2
-
- Fungal Infections and Studies 2
- Co-authors
- Richard C. Brundage (4 shared papers)David R. Boulware (2 shared papers)Kyle D. Smith (1 shared paper)Lillian Tugume (2 shared papers)Abdu K Musubire (2 shared papers)Reuben Kiggundu (1 shared paper)Darlisha A Williams (2 shared papers)Mahsa Abassi (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Pharmacology & Therapeutics (2 papers)CPT Pharmacometrics & Systems Pharmacology (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)The AAPS Journal (1 paper)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Ali Alhadab
11 papers receiving 193 citations
Peers
Comparison fields: 5 of 51
- Infectious Diseases 112
- Epidemiology 114
- Applied Microbiology and Biotechnology 5
- Pharmacology 29
- Microbiology 10
Countries citing papers authored by Ali Alhadab
This map shows the geographic impact of Ali Alhadab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Alhadab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Alhadab more than expected).
Fields of papers citing papers by Ali Alhadab
This network shows the impact of papers produced by Ali Alhadab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Alhadab. The network helps show where Ali Alhadab may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Alhadab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 123 | |
| 2 | 2018 | 15 | |
| 3 | 2020 | 13 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 7 | |
| 6 | 2020 | 7 | |
| 7 | 2021 | 4 | |
| 8 | 2019 | 4 | |
| 9 | 2020 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 3 |
About Ali Alhadab
Ali Alhadab is a scholar working on Oncology, Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine and Pharmacology, having authored 11 papers that have together received 195 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Antifungal resistance and susceptibility (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Fungal Infections and Studies (2 papers), Lung Cancer Research Studies (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Infectious Diseases (112 citations), Epidemiology (114 citations), Applied Microbiology and Biotechnology (5 citations), Pharmacology (29 citations) and Microbiology (10 citations). Ali Alhadab has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Richard C. Brundage, David R. Boulware, Kyle D. Smith, Lillian Tugume, Abdu K Musubire, Reuben Kiggundu, Darlisha A Williams, Mahsa Abassi, Kathy Huppler Hullsiek and Kirsten Nielsen. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Antimicrobial Agents and Chemotherapy and The AAPS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.